These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26208600)

  • 21. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
    Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
    Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.
    Sack JS; Gao M; Kiefer SE; Myers JE; Newitt JA; Wu S; Yan C
    Acta Crystallogr F Struct Biol Commun; 2016 Feb; 72(Pt 2):129-34. PubMed ID: 26841763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MARK4 protein can explore the active-like conformations in its non-phosphorylated state.
    Ahrari S; Khosravi F; Osouli A; Sakhteman A; Nematollahi A; Ghasemi Y; Savardashtaki A
    Sci Rep; 2019 Sep; 9(1):12967. PubMed ID: 31506531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
    Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
    Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
    Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
    Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4.
    Anwar S; Khan S; Anjum F; Shamsi A; Khan P; Fatima H; Shafie A; Islam A; Hassan MI
    J Cell Biochem; 2022 Feb; 123(2):359-374. PubMed ID: 34751461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.
    Anwar S; Choudhury A; Hussain A; AlAjmi MF; Hassan MI; Islam A
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130090. PubMed ID: 38342269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition.
    Anwar S; Shamsi A; Shahbaaz M; Queen A; Khan P; Hasan GM; Islam A; Alajmi MF; Hussain A; Ahmad F; Hassan MI
    Sci Rep; 2020 Jun; 10(1):10300. PubMed ID: 32587267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression.
    Jenardhanan P; Mannu J; Mathur PP
    Mol Biosyst; 2014 Jul; 10(7):1845-68. PubMed ID: 24763618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli.
    Naz F; Asad M; Malhotra P; Islam A; Ahmad F; Hassan MI
    Appl Biochem Biotechnol; 2014 Mar; 172(6):2838-48. PubMed ID: 24446173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis.
    Qin YS; Li H; Wang SZ; Wang ZB; Tang CK
    J Cell Physiol; 2022 Jan; 237(1):86-97. PubMed ID: 34289095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and dynamics of inactive and active MARK4: conformational switching through the activation process.
    Ahrari S; Mogharrab N; Navapour L
    J Biomol Struct Dyn; 2020 May; 38(8):2468-2481. PubMed ID: 31411112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases.
    Alam M; Ahmed S; Abid M; Hasan GM; Islam A; Hassan MI
    J Cell Biochem; 2023 Sep; 124(9):1223-1240. PubMed ID: 37661636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism.
    Samra S; Sharma M; Vaseghi-Shanjani M; Del Bel KL; Byres L; Lin S; Dalmann J; Salman A; Mwenifumbo J; Modi BP; Biggs CM; Boelman C; Clarke LA; Lehman A; Turvey SE
    HGG Adv; 2024 Jan; 5(1):100259. PubMed ID: 38041405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.
    Atiya A; Alsayari A; Bin Muhsinah A; Almaghaslah D; Bilgrami AL; Abdulmonem WA; Alorfi NM; DasGupta D; Ashraf GM; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023; 41(18):8824-8830. PubMed ID: 36376029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Characterization of Microtubule Affinity-Regulating Kinase4 from
    Tian L; Wen A; Dong S; Yan P
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.